Beijing WellGene Biotech Co., Ltd.
PrivateLast Round
Series C
May 22, 2023
Total Funding Raised
$58.01M
Company Overview
Beijing WellGene Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C round in May 2023.
Beijing WellGene Biotech Co., Ltd. is a biotechnology company that develops gene therapy drugs and oncolytic virus therapies for the treatment of tumors, skin diseases, and other rare or refractory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing WellGene Biotech Co., Ltd. Comparables
Compare Beijing WellGene Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmVira | 85% | |
| Virogin Biotech | 85% | |
| Wuhan Binhui Biopharmaceutical Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Beijing WellGene Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 22, 2023 | ||||
| Series B | Nov 1, 2020 | ||||
| Series A | Sep 1, 2019 |
For institutional investors. Book with your work email.
Beijing WellGene Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fengchuan Capital | Series B, Series C |
| Shanghai Science and Technology Innovation Group | Series C |
| Beijing Zhongguancun Science City Innovation Development Co., Ltd. | Series C |
| SDIC Venture Capital | Series C, Series B |
| Guangdong Shunde Kechuang Management Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2020
$15.15M round led by SDIC Venture Capital
- Sep 1, 2019
Completed a Series A funding round.
For institutional investors. Book with your work email.
Beijing WellGene Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing WellGene Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Beijing WellGene Biotech Co., Ltd. a public or private company?
Beijing WellGene Biotech Co., Ltd. is a private company.
What is the current stock price of Beijing WellGene Biotech Co., Ltd.?
Beijing WellGene Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing WellGene Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing WellGene Biotech Co., Ltd. worth (valuation)?
Valuation information for Beijing WellGene Biotech Co., Ltd. is not publicly available.
Can I buy Beijing WellGene Biotech Co., Ltd. stock?
Beijing WellGene Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing WellGene Biotech Co., Ltd.'s last funding round?
Beijing WellGene Biotech Co., Ltd.'s most recent funding round was Series C on May 22, 2023.
Who are the main investors in Beijing WellGene Biotech Co., Ltd.?
Key investors in Beijing WellGene Biotech Co., Ltd. include SDIC Venture Capital.
Will Beijing WellGene Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing WellGene Biotech Co., Ltd..
How can I track Beijing WellGene Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing WellGene Biotech Co., Ltd.'s shares on secondary markets.